Hepatitis E virus (HEV), a hepatotropic virus, is transmitted through consumption of contaminated food and water. Infection with HEV can result in acute viral hepatitis or acute liver failure; certain viral genotypes are also known to cause chronic infection in immunosuppressed persons. This ...
Recombinant hepatitis E virus vaccine: A successful Phase II trial in a disease-endemic regionhepatitis E vaccinePhase II trialAuthor(s): Kris Krawczynski 1 Keywords: hepatitis E vaccine; Phase II trial Prevention of hepatitis E, a disease occurring in large outbreaks of acute hepatitis in ...
(FDA,2012; Yugo and Meng,2013). Treatment is aimed at preventing the symptoms, because there is no specific treatment for hepatitis; also, although there are vaccines for other forms of hepatitis (FDA,2012), thehepatitis E vaccinehas recently become available only in China but not in other ...
All children should receive hepatitis A vaccine at 1 year of age (i.e., 12 through 23 months). Vaccination should be completed according to the licensed schedules and integrated into the recommended childhood immunization schedule. Children who are not vaccinated by 2 years of age can be vaccin...
Hepatitis A is a vaccine-preventable infection caused by the hepatitis A virus (HAV). Over 150 million new infections of hepatitis A occur annually. HAV causes an acute inflammatory reaction in the liver that usually resolves spontaneously without chroni
The hepatitis E vaccine provided sustained protection against the virus for up to 4.5 years, found a follow-up study to a 2007 randomized trial that evaluated the short-term efficacy of the vaccine Hecolin. The initial phase 3 clinical trial randomly assigned 112 604 healthy adults aged 16 ...
Hepatitis B vaccine Hepatitis B vaccine is a vaccine developed for the prevention of hepatitis B virus infection. The vaccine contains one of the viral
Hepatitis E virus (HEV) is a public health concern in both developing and developed countries. Here, the authors describe advances in understanding HEV biology, clinical infection and the challenges still to be overcome in HEV research, particularly with
VaccineAdvanceHepatitis E is an emerging global disease caused by hepatitis E virus (HEV) infection. While in developing countries the infection was primarily due to poor sanitary conditions through intake of contaminated water or undercooked meats of infected animals, increasing cases of chronic ...
Novaccinecan prevent the hepatitis E virus. It’s most common in less-developed countries in Asia, the Middle East, Africa, and Central America. You can lower your chances of getting the virus if you: Don’t drink water or use ice that you don’t know is clean. ...